A Detailed Analysis of the IV Fluid Transfer Drug Devices Market Based on Rising Healthcare Needs, Technological Advancements, and Closed-system Adoption
Report ID: PMRREP33966
Number of Pages: 197
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: February-2024
1. Executive Summary
1.1. Global IV Fluid Transfer Drug Devices Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Application Lifecycle Analysis
2.4. IV Fluid Transfer Drug Devices Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global IV Fluid Transfer Drug Devices Market Outlook: Application
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.3.3.1. Autoimmune Diseases
3.3.3.2. Blood Disorders
3.3.3.3. Cardiovascular Disorders
3.3.3.4. Neurology
3.3.3.5. Oncology
3.3.3.6. Others
3.4. Market Attractiveness Analysis: Application
3.5. Global IV Fluid Transfer Drug Devices Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Hospitals
3.5.3.2. Specialized Clinics
3.5.3.3. Others
3.6. Market Attractiveness Analysis: End User
4. Global IV Fluid Transfer Drug Devices Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Application
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.5.1. Autoimmune Diseases
5.5.2. Blood Disorders
5.5.3. Cardiovascular Disorders
5.5.4. Neurology
5.5.5. Oncology
5.5.6. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Hospitals
5.6.2. Specialized Clinics
5.6.3. Others
5.7. Market Attractiveness Analysis
6. Europe IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Application
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.5.1. Autoimmune Diseases
6.5.2. Blood Disorders
6.5.3. Cardiovascular Disorders
6.5.4. Neurology
6.5.5. Oncology
6.5.6. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Hospitals
6.6.2. Specialized Clinics
6.6.3. Others
6.7. Market Attractiveness Analysis
7. East Asia IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Application
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.5.1. Autoimmune Diseases
7.5.2. Blood Disorders
7.5.3. Cardiovascular Disorders
7.5.4. Neurology
7.5.5. Oncology
7.5.6. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Hospitals
7.6.2. Specialized Clinics
7.6.3. Others
7.7. Market Attractiveness Analysis
8. South Asia & Oceania IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Application
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.5.1. Autoimmune Diseases
8.5.2. Blood Disorders
8.5.3. Cardiovascular Disorders
8.5.4. Neurology
8.5.5. Oncology
8.5.6. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Hospitals
8.6.2. Specialized Clinics
8.6.3. Others
8.7. Market Attractiveness Analysis
9. Latin America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Application
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.5.1. Autoimmune Diseases
9.5.2. Blood Disorders
9.5.3. Cardiovascular Disorders
9.5.4. Neurology
9.5.5. Oncology
9.5.6. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Hospitals
9.6.2. Specialized Clinics
9.6.3. Others
9.7. Market Attractiveness Analysis
10. Middle East & Africa IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Application
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.5.1. Autoimmune Diseases
10.5.2. Blood Disorders
10.5.3. Cardiovascular Disorders
10.5.4. Neurology
10.5.5. Oncology
10.5.6. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Hospitals
10.6.2. Specialized Clinics
10.6.3. Others
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Application Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Advance Medical Designs Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Application
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. B. Braun Medical
11.3.2.1. Overview
11.3.2.2. Segments and Application
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Baxter Healthcare
11.3.3.1. Overview
11.3.3.2. Segments and Application
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. ICU Medical Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Application
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Hospira
11.3.5.1. Overview
11.3.5.2. Segments and Application
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Q.I. Medical Inc.
11.3.6.1. Overview
11.3.6.2. Segments and Application
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Pfizer
11.3.7.1. Overview
11.3.7.2. Segments and Application
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Unilife Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Application
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Amedra Pharmaceuticals
11.3.9.1. Overview
11.3.9.2. Segments and Application
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Sanofi
11.3.10.1. Overview
11.3.10.2. Segments and Application
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Biogen Idec
11.3.11.1. Overview
11.3.11.2. Segments and Application
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. BIONIK Laboratories Corp.
11.3.12.1. Overview
11.3.12.2. Segments and Application
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Ekso Bionics Holdings Inc.
11.3.13.1. Overview
11.3.13.2. Segments and Application
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations